BML Capital Management, LLC
CIK
1616824
Location
ZIONSVILLE, IN
Portfolio Value
Micro
$7,397,883
Diversification
Moderately concentrated
Filing Date
Global Rank
#4,423
/ 8,232
▲ 964
Top Industry
Biotechnology
80.8%
3Y Alpha vs SPY
+35.5%
Period ended 3 months ago
Filed May 6, 2026 · 40d
14 quarters · since Dec 2022
Clone Performance
Jun 2023–Jun 2026 · vs SPYHypothetical growth of cloning every reported 13F position and rebalancing on each filing, indexed to the same start.
Cloned portfolio
+275.3%
SPY
+74.2%
Annualised alpha
+35.1%
Max drawdown
−46.9%
Estimate. 13F holdings are quarter-lagged and long-only, so the clone rebalances about 45 days after each period end — when the filing becomes public — and excludes options and short positions. Past performance does not predict future results.
Portfolio Concentration
16 positions · as of Mar 31, 2026 · Δ vs Dec 31, 2025Top Position
34.4%
−3.4 pts
Top 5
76.0%
−5.3 pts
Top 10
94.2%
−3.1 pts
HHI
1,954
Moderately concentrated−227
Portfolio Trend
14 quarters · across all stocks
Sector Breakdown
As of Mar 31, 2026| Sector | % Portfolio | Value |
|---|---|---|
| Healthcare | 85.5% | $132,927,915 |
| Consumer Cyclical | 9.7% | $15,152,400 |
| Consumer Defensive | 4.8% | $7,397,883 |
Last Quarter's Activity
Export CSVTrimmed
Positions the filer reduced
1 positions
| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| AVIR | Atea Pharmaceuticals, Inc. | −431,343 | 7,058,657 | $37,975,574 | |
| No positions match the current search. | |||||
3 positions ·
$7,397,883 total
· Consumer Defensive only
· as of Mar 31, 2026
| Ticker | Company | Type | Shares | Value (USD) | % of Portfolio | History |
|---|---|---|---|---|---|---|
| TGT |
Target Corp
Consumer Defensive
|
Held | 37,500 | $4,545,000 | 61.44% | |
| KHC |
Kraft Heinz Co
Consumer Defensive
|
NEW | 125,000 | $2,811,250 | 38.00% | |
| WMT |
Walmart Inc.
Consumer Defensive
|
Held | 335 | $41,633 | 0.56% |